Texas HB2295 amends newborn screening tests to include Duchenne muscular dystrophy.

Texas HB2295 amends the Health and Safety Code to include newborn screening tests for Duchenne muscular dystrophy, phenylketonuria, other heritable diseases, and hypothyroidism. The bill requires the Department of State Health Services to notify parents and physicians if a newborn screens positive for these conditions. It also mandates the department to establish a laboratory for developing screening and diagnostic tests for early detection and treatment of these disorders. The changes must be implemented by September 1, 2027.

Texas HB2295 amends newborn screening tests to include Duchenne muscular dystrophy.

Texas HB2295 amends the Health and Safety Code to include newborn screening tests for Duchenne muscular dystrophy, phenylketonuria, other heritable diseases, and hypothyroidism. The bill requires the Department of State Health Services to notify parents and physicians if a newborn screens positive for these conditions. It also mandates the department to establish a laboratory for developing screening and diagnostic tests for early detection and treatment of these disorders. The changes must be implemented by September 1, 2027.